Posts Tagged ‘Monsanto’

Study Finds Genetically Modified Corn Causing Organ Damage To Rats

Study Finds Genetically Modified Corn Causing Organ Damage To Rats

corn - tbiCourtesy of Vincent Fernando at Clusterstock/The Business Insider

A new study concludes that some varieties of genetically modified corn may cause organ damage.

Regardless of which specific varieties of genemtic modification might be dangerous, if serious health risks were proven for any genetically modified type of food, it could hit all types since the level of regulatory scrutiny would likely increase ten-fold.

It would most certainly be bad news for Monsanto (MON).

Journal of Biological Sciences: We therefore conclude that our data strongly suggests that these GM maize varieties induce a state of hepatorenal toxicity. This can be due to the new pesticides (herbicide or insecticide) present specifically in each type of GM maize, although unintended metabolic effects due to the mutagenic properties of the GM transformation process cannot be excluded [42]. All three GM maize varieties contain a distinctly different pesticide residue associated with their particular GM event (glyphosate and AMPA in NK 603, modified Cry1Ab in MON 810, modified Cry3Bb1 in MON 863). These substances have never before been an integral part of the human or animal diet and therefore their health consequences for those who consume them, especially over long time periods are currently unknown….

In conclusion, our data presented here strongly recommend that additional long-term (up to 2 years) animal feeding studies be performed in at least three species, preferably also multi-generational, to provide true scientifically valid data on the acute and chronic toxic effects of GM crops, feed and foods.

Read more here >

We’d be curious to see how this pans out, it seems to be far from a done deal given that they recommend doing further study in order to achieve ‘true scientifically valid data’. It also seems that the problem may have had more to do with the pesticides involved rather than the actual act of modifying genes.

As always, one needs to balance the benefits vs. the cost of any technology. We’re reminded of how food preservatives came under fire as unhealthy additives, without regard to the fact that large amounts of people used to die on a regular basis from food poisoning before their broad usage. Still, if the danger is real, it should obviously be investigated. Hopefully, for the sake of agricultural productivity, there aren’t any major health risks.

(Via Naked Capitalism)

 


Tags: , , , , , , , ,




Is Monsanto Worth a Look? Depends on Which Monsanto You’re Talking About.

Is Monsanto Worth a Look? Depends on Which Monsanto You’re Talking About.

Disclaimer:  This is not research, advice or an invitation to trade or invest.  My comments below are simply some observations based on publicly available information.  Do not trade based on anything you read here.

Monsanto (MON) is becoming quite the controversial stock in light of the dichotomy of near-term and long-term outlooks.  You could make the case that this is true for all of the agriculture stocks (brutal farm incomes and spending this year but multi-year Ag Supercycle on the horizon). 

Roundup - the trouble with Monsanto

Let’s look at MON as a microcosm for the ag story at large…

Monsanto’s long-term story is one of the most exciting and imagination-capturing I can think of.

The short version goes something like this: 

The planet’s population is not only growing, it is becoming more prosperous.  As a result, the emerging middle class (China, Latin America, India, Africa) will be looking to upgrade the food they consume and to include more proteins in their diet.  In order to meet this new protein demand, roughly four times the amount of productivity will be required of the available global farmland.  The best way to accomplish this is with enhanced seed and genomic technology, which puts the industry leader, Monsanto, squarely in the driver’s seat for this global mega-trend.

OK, this is all well and good, but right now in 2009, the $43 billion dollar company is not quite being driven by the Ag-Tech story, it is instead being driven in part by the results of its weed-killer business, also known as Roundup.

Monsanto put out an earnings forecast this week and had to lower its 2009 and 2010 profit estimates in light of the fact that consumers are skipping the brand-name Roundup product in favor of cheaper generic herbicides.

roundup on monsantoThe company is pegging its 2010 earnings at $3.10 to $3.30 a share, The Street was thinking more like $4.30.  Not pretty.

Monsanto’s CEO is telling us that the Roundup business will only be 15% of the profit mix at Monsanto by 2012 as the seed and genomic businesses kick into high gear and go to 85% of profits.  The question becomes whether or not you are willing to see through the valley into the intermediate term when this prospect has the potential to become reality. 

The analysts I’ve…
continue reading


Tags: , , , ,




 
 
 

Zero Hedge

These Are The Most (And Least) Generous Countries In The World

Courtesy of ZeroHedge View original post here.

The Charities Aid Foundation has released the 2019 edition of the World Giving Index which surveyed 1.3 million people in 128 countries to determine generosity levels.

Unfortunately, as Statista...



more from Tyler

Phil's Favorites

How Asia transformed from the poorest continent in the world into a global economic powerhouse

 

How Asia transformed from the poorest continent in the world into a global economic powerhouse

By sladkozaponi/Shutterstock

Courtesy Deepak Nayyar, University of Oxford

In 1820, Asia accounted for two-thirds of the world’s population and more than one-half of global income. The subsequent decline of Asia was attributed to its integration with a world economy shaped by colonialism and driven by imperialism.

By the late 1960s, Asia was the ...



more from Ilene

Digital Currencies

Five hurdles blockchain faces to revolutionise banking

 

Five hurdles blockchain faces to revolutionise banking

Shutterstock

Courtesy of Markos Zachariadis, Warwick Business School, University of Warwick

Blockchain is touted as the next step in the digital revolution, a technology that will change every industry from music to wast...



more from Bitcoin

Chart School

Gold Stocks Review

Courtesy of Read the Ticker

Gold stocks are swinging back forth between the range, and a break out swing higher is due. Gold stocks are holding a near perfect Wyckoff accumulation pattern. All should get ready to play this sector. Yet we must recognize that gold stocks are a one of the most crazy rides at the stock market fair, so play very carefully.

More from RTT Tv







GDX PnF chart from within the video

Click for popup. Clear your browser cache if image is not showing.




Important channels around the HUI.
...

more from Chart School

The Technical Traders

Treasuries Pause Near Resistance Before The Next Rally

Courtesy of Technical Traders

Our research team believes the US Treasuries and the US Dollar will continue to strengthen over the next 2 to 6+ weeks as foreign market and emerging market credit and debt concerns outweigh any concerns originating from the US economy or political theater.  Overall, the major global economies will likely continue to see strength related to their currencies and debt instruments simply because the foreign market and emerging markets are dramatically more fragile than the more mature major global economies.

We believe the US Treasuries may surprise investors by rallying from current levels, near price resistance, to levels above $151 on the TLT chart. 

Our belief ...



more from Tech. Traders

Insider Scoop

48 Biggest Movers From Yesterday

Courtesy of Benzinga

Gainers
  • Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares climbed 43.2% to close at $3.58 on Thursday after the company announced the publication of a research article, "A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models," in the peer-reviewed Journal of Pharmacology and Experimental Therapeutics.
  • Synthesis Energy Systems, Inc. (NASDAQ: SES) rose 26.9% to close at $9.20 after surging 12.24% on Wednesday.
  • Assembly Biosciences, Inc...


http://www.insidercow.com/ more from Insider

Kimble Charting Solutions

Bank Index Breakout? Stock Market Bulls Sure Hope So

Courtesy of Chris Kimble

One of the most important sectors of the stock market is the banking industry and bank stocks.

When the banks are healthy, the economy is likely doing well. And when bank stocks are participating in a market rally, then it bodes well for the broader stock market.

In today’s chart, we look at the Bank Index (BKX).

As you can see, the banks have been in a falling channel for the past 20 months. As well, the banks have been lagging the broader market during this time as well – see the Ratio in the bottom half of the chart above.

That said, th...



more from Kimble C.S.

Lee's Free Thinking

Look Out Bears! Fed New QE Now Up to $165 Billion

Courtesy of Lee Adler

I have been warning for months that the Fed would need new QE to counter the impact of massive waves of Treasury supply. I thought that that would come later, rather than sooner. Sorry folks, wrong about that. The NY Fed announced another round of new TOMO (Temporary Open Market Operations) today.

In addition to the $75 billion in overnight repos that the Fed issued and has been rolling over since Tuesday, next week the Fed will issue another $90 billion. They’ll come in the form of three $30 billion, 14 day repos to be offered next week.

That brings the new Fed QE to a total of $165 billion. Even in the worst days of the financial crisis, I can’t remember the Fed ballooning its balance sheet by $165 bi...



more from Lee

Biotech

The Big Pharma Takeover of Medical Cannabis

Reminder: We are available to chat with Members, comments are found below each post.

 

The Big Pharma Takeover of Medical Cannabis

Courtesy of  , Visual Capitalist

The Big Pharma Takeover of Medical Cannabis

As evidence of cannabis’ many benefits mounts, so does the interest from the global pharmaceutical industry, known as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry—once heavily stigmatized, it is now a potentially game-changing source of growth for countless co...



more from Biotech

Mapping The Market

How IPOs Are Priced

Via Jean Luc 

Funny but probably true:

...

more from M.T.M.

Members' Corner

Despacito - How to Make Money the Old-Fashioned Way - SLOWLY!

Are you ready to retire?  

For most people, the purpose of investing is to build up enough wealth to allow you to retire.  In general, that's usually enough money to reliably generate a year's worth of your average income, each year into your retirement so that that, plus you Social Security, should be enough to pay your bills without having to draw down on your principle.

Unfortunately, as the last decade has shown us, we can't count on bonds to pay us more than 3% and the average return from the stock market over the past 20 years has been erratic - to say the least - with 4 negative years (2000, 2001, 2002 and 2008) and 14 positives, though mostly in the 10% range on the positives.  A string of losses like we had from 2000-02 could easily wipe out a decades worth of gains.

Still, the stock market has been better over the last 10 (7%) an...



more from Our Members

Promotions

Free eBook - "My Top Strategies for 2017"

 

 

Here's a free ebook for you to check out! 

Phil has a chapter in a newly-released eBook that we think you’ll enjoy.

In My Top Strategies for 2017, Phil's chapter is Secret Santa’s Inflation Hedges for 2017.

This chapter isn’t about risk or leverage. Phil present a few smart, practical ideas you can use as a hedge against inflation as well as hedging strategies designed to assist you in staying ahead of the markets.

Some other great content in this free eBook includes:

 

·       How 2017 Will Affect Oil, the US Dollar and the European Union

...

more from Promotions





About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>